The European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual), is the most important congress in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.
It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.
Fast facts: ELCC 2021 Virtual
- Expecting over 2000 international participants
- Specialists and Key Opinion Leaders (KOLs) from all over the world together on one virtual congress platform
- 14 educational and 3 key note lectures
- An internationally renowned faculty
- 8 Industry Satellite Symposia
- Interactive Virtual Exhibition
- Various online networking and engagement opportunities
Past attendance
ESMO gratefully acknowledges the valuable contribution of the following organisations in the ELCC Congresses over the years.
Past attendees | ||
|---|---|---|
Abbott Laboratories |
Daiichi Sankyo Oncology Europe GmbH |
Olympus Medical Systems Europe |
AbbVie |
Elsevier |
Otsuka Pharmaceuticals |
Agennix |
Eli Lilly and Company |
Pfizer Oncology |
Amgen |
Epigenomics |
PharmaMar, S.A. |
Amoy Diagnostics Co. Ltd |
GE Healthcare |
prIME Oncology |
Ariad Pharmaceuticals |
GSK |
Qiagen |
AstraZeneca |
Helsinn Healthcare |
Roche |
Bavarian Nordic |
Incyte |
Rosetta Genomics |
Bayer |
Karl Storz |
Sanofi |
Beacon |
Merck-Pfizer Alliance |
Sysmex Europe GmbH |
Biocartis |
Merck Serono |
Takeda Pharmaceuticals International AG |
Boehringer Ingelheim |
Microsulis Medical Ltd. |
Thermo Fisher Scientific |
Bristol-Myers Squibb |
MSD |
Varian Medical Systems |
Cis Bio International |
Neogenomics |
Wisepress Ltd |
Clovis Oncology |
Novartis |
|
How can I participate in ELCC 2021 Virtual?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congresses.
Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!